Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.
In ‘Destination Anywhere’ Melanie Oliveiro finds out what it's like to live in a pod or capsule hotel room while ...
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)Findings in ...
In ‘Made in SG’ Melanie Oliveiro speaks with the three co-founders of Alchemist Travel, a luxury travel agency created and ...
The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...
Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including ...
Experts say it’s an opportunity to help address barriers for people such as racialized immigrants and refugees, Indigenous ...
Hilderley, who has late-stage cervical cancer, has become an advocate for the new screening tool to help others avoid a ...
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD ...
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...